Skip to main content
. Author manuscript; available in PMC: 2020 Oct 1.
Published in final edited form as: Exp Neurol. 2019 Jul 8;320:113007. doi: 10.1016/j.expneurol.2019.113007

Fig. 2.

Fig. 2.

The expression of serum FGF21, cerebral FGF21 and FGFR1 after MCAO/recanalization. (A) Quantitative analyses of serum FGF21; (B) Representative Western blots images; (C–E) Quantitative analyses of cerebral FGF21 and p-FGFR1, & p < 0.05, vs sham, $ p < 0.05, vs pMCAO 3d, # p < 0.05, vs pMCAO 4d, * p < 0.05, vs pMCAO 10d, n = 6 per group, One-way ANOVA-Tukey. FGF21, fibroblast growth factor 21; FGFR1, fibroblast growth factor receptor 1; p-FGFR1, phosphorylated FGFR1; pMCAO, permanent middle cerebral artery occlusion; rMCAO, recanalization at 3 d after MCAO; d, day.